“…[2][3][4][5][6][7][8][9][10] In healthy subjects in the steady state, CRP concentrations are 100-to 1000-fold lower than those found during acute infection and inflammation and lie in the range of 0.1 to 10 mg/L. Steady-state CRP concentrations are approximately 2-fold higher in patients with stable coronary heart disease (CHD), 11,12 but when an acute coronary syndrome supervenes, CRP concentrations rise acutely, with the level attained predicting the probability of an additional CHD event in the short to intermediate term. [13][14][15][16][17] CRP is present in atherosclerotic plaques, 18 where it might exert several potential proinflammatory and atherogenic actions that include the binding of oxidized LDL cholesterol, 19 induction of adhesion molecule expression, 20 activation of complement, 18 and stimulation of tissue factor production by monocytes.…”